PrimeraDx Develops Instrument for Detection and Quantification of Target Types

PrimeraDx has launched the ICEPlex® system, an instrument for simultaneous detection and quantification of disparate target types, such as mRNA, miRNA, SNPs, and DNA

PrimeraDx has developed an open platform enabling clinical labs to easily develop cost-effective, high-impact molecular diagnostic tests. The ICEPlex instrument has already been placed with a number of key accounts, including large academic research centers, reference laboratories, and bio-pharmaceutical companies. The ICEPlex instrument has a simple workflow and comes with on-board software for assay design, data analysis, and reporting.

Source: PrimeraDx